Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Aubagio, teriflunomide
Also known as: HMR1726
print preview
bookmark
share with colleague
General Information
Company
Sanofi
Description
Dihydroorotate dehydrogenase (DHODH) inhibitor
Molecular Target
Dihydroorotate dehydrogenase (DHODH)
Mechanism of Action
Dihydroorotate dehydrogenase (DHODH) inhibitor; Immune modulation
Latest Stage of Development
Marketed
Indication
Multiple sclerosis (MS)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy